Compare DRVN & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRVN | RXRX |
|---|---|---|
| Founded | 1972 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Automotive Aftermarket | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2020 | 2021 |
| Metric | DRVN | RXRX |
|---|---|---|
| Price | $11.61 | $4.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 7 |
| Target Price | ★ $16.09 | $7.22 |
| AVG Volume (30 Days) | 1.1M | ★ 16.5M |
| Earning Date | 11-03-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.70 | 14.79 |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $1,862,438,000.00 | $74,681,000.00 |
| Revenue This Year | $7.70 | N/A |
| Revenue Next Year | $9.05 | $34.96 |
| P/E Ratio | $22.04 | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $9.80 | $2.77 |
| 52 Week High | $17.30 | $7.18 |
| Indicator | DRVN | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 37.92 | 63.19 |
| Support Level | $9.92 | $4.05 |
| Resistance Level | $13.57 | $5.12 |
| Average True Range (ATR) | 0.43 | 0.24 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 0.95 | 95.50 |
Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments; Take 5, Franchise Brands, and Auto Glass Now. It derives maximum revenue from Take 5 Segment. Geographically, the company operates into United States, Canada and Rest of the World.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.